The prognostic significance of estradiol (ER) and progesterone receptors (PgR) for survival from relapse has been studied in two groups of breast cancer patients: group 1, 35 patients in whom receptor levels were measured at the time of mastectomy; group II, 49 patients in whom receptor levels were measured at the time of recurrence. ER+ (greater than 10 fmoles/mg) patients had a better survival from relapse than ER- patients. High levels of PgR (greater than 50 fmoles/mg) had a prognostic significance only in group II patients.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/BF01805988 | DOI Listing |
Publication Analysis
Top Keywords
group patients
12
estradiol progesterone
8
progesterone receptors
8
breast cancer
8
prognostic significance
8
survival relapse
8
patients receptor
8
receptor levels
8
levels measured
8
measured time
8
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!